Gradalis
Phase 2Gradalis is a late stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
Founded
2006
Focus
BiologicsRNA & Gene Therapy
About
Gradalis is a late stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
Funding History
3Total raised: $75M
Series C$40MUndisclosedJun 15, 2016
Series B$25MUndisclosedJun 15, 2013
Series A$10MUndisclosedJun 15, 2010
Company Info
TypePrivate
Founded2006
LocationDallas, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile